A study on the U.S. banking system found nearly 190 banks are at risk of failure. Preston D. Cherry, founder and president of Concurrent Financial Planning, joined Cheddar News to explain the process if you have a mortgage with a bank that collapses.
Share:
More In Business
Everything You Need to Know About Universal Epic Universe
Universal's newest park hosts themed worlds for Super Mario Bros., "How to Train Your Dragon," and more.
This Might Be the Coolest Thing From Google I/O 2025—Here’s Why
Managing Editor at Tom's Guide Kate Kozuch, discusses why the most captivating technology will soon be right in front of your nose, literally.
Report: Smoke filled the cabin of a Delta plane in Atlanta
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Top Travel Tips for Memorial Day Weekend 2025
AAA spokesperson, Aixa Diaz, gives her top tips for the record-breaking travel expected this Memorial Day weekend. Find out what you need to know!
Leading with Integrity: How a Family Brand Became a Pioneer in Organic Food
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Levi Strauss agrees to sell Casual Friday staple Dockers for up to $391 million
Levi Strauss is set to finally part ways with Dockers.
A Look Inside How Small Businesses Are Facing Tariffs
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
How Babylist Is Changing the Way You Get Ready for That Newest Family Member
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
